Literature DB >> 6661225

The amidating enzyme in pituitary will accept a peptide with C-terminal D-alanine as substrate.

A E Landymore-Lim, A F Bradbury, D G Smyth.   

Abstract

A series of tripeptides which terminated in d-alanine, d-serine, d-leucine or l-alanine was synthesized and the peptides tested for their ability to act as substrates for an amidating enzyme present in porcine pituitary. The peptides were allowed to compete with a radiolabelled substrate 125I d-Tyr Phe Gly in the presence of a rate limiting concentration of amidating enzyme and the degree of conversion to 125I d-Tyr Phe amide was determined by ion exchange chromatography. An accelerated procedure was developed for investigating the rates of reaction. The results showed that d-Tyr Phe d-Ala has a significant affinity for the amidating enzyme; no affinity could be demonstrated with d-Tyr Phe 1-Ala, d-Tyr Phe d-Ser or d-Tyr Phe d-Leu. Direct evidence that d-Tyr Phe d-Ala can undergo amidation was obtained by incubating the 125I labelled tripeptide with the pituitary enzyme. Amidation took place readily with d-Tyr Phe d-Ala but not with the other tripeptides; thus, while the enzyme is unable to catalyse the conversion of a peptide terminating in 1-alanine, it can accept a peptide terminating in d-alanine. The results indicate that the amidating enzyme has a highly compact substrate binding site.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661225     DOI: 10.1016/0006-291x(83)91573-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Identity of a second type of allatostatin from cockroach brains: an octadecapeptide amide with a tyrosine-rich address sequence.

Authors:  G E Pratt; D E Farnsworth; K F Fok; N R Siegel; A L McCormack; J Shabanowitz; D F Hunt; R Feyereisen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 2.  Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases.

Authors:  David J Merkler; Aidan J Hawley; Betty A Eipper; Richard E Mains
Journal:  Br J Pharmacol       Date:  2022-02-28       Impact factor: 9.473

3.  Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).

Authors:  David J Merkler; Alexander S Asser; Laura E Baumgart; Natalie Carballo; Sarah E Carpenter; Geoffrey H Chew; Casey C Cosner; Jodi Dusi; Lamar C Galloway; Andrew B Lowe; Edward W Lowe; Lawrence King; Robert D Kendig; Paul C Kline; Robert Malka; Kathleen A Merkler; Neil R McIntyre; Mindy Romero; Benjamin J Wilcox; Terence C Owen
Journal:  Bioorg Med Chem       Date:  2008-10-11       Impact factor: 3.641

4.  Peptidyl-glycine alpha-amidating mono-oxygenase activity towards a gonadotropin-releasing-hormone C-terminal peptide substrate, in subcellular fractions of sheep brain and pituitary.

Authors:  J S Gale; J E McIntosh; R P McIntosh
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.